Hans Keirstead, professor of anatomy & neurobiology, in 2004 developed a stem cell therapy that restored greater mobility in animal models (rats) with spinal cord injury. In 2009, the U.S. Food & Drug Administration approved human clinical trials, conducted by Geron Corp., based on Keirstead’s treatment. It was the world’s first embryonic stem cell therapy tested in humans. Read more here.
March 01, 2004